An animated rendering of the Allia Moveo platform. [Image from GE HealthCare] GE HealthCare (Nasdaq: GEHC)…
Continue ReadingTag: Mark
GE Healthcare’s Allia Moveo Platform Receives FDA Clearance, CE Mark
Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug…
Continue Reading
GE HealthCare’s Allia Moveo gains FDA and CE mark approvals
GE HealthCare’s Allia Moveo system GE HealthCare has announced that its Allia Moveo image-guidance platform has…
Continue Reading
GE HealthCare secures FDA clearance and CE mark for deep learning tech
GE HealthCare announced the FDA submission at the Radiological Society of North America’s (RSNA) 2024 meeting…
Continue Reading
Improving Cancer Patient Care With Professor Mark Lawler
Mark Lawler, professor of digital health, is a leader in cancer research with a focus on…
Continue Reading